Furthermore, treatment with DNA-damaging drugs, such as hydroxyurea, previously shown to induce the loss of DMs in different cells [7,17] do not have an effect on the levels of DMs in HER2-amplified breast cancer cells (data not shown). Here, ERBB2 is linked to breast carcinoma.